FDA Recommends Transitioning Away from Use of Decontaminated Disposable Respirators

AHA Special Bulletin
April 10, 2021


The Food and Drug Administration today urged health care facilities to transition away from using crisis capacity conservation strategies, such as decontamination or bioburden reduction, to extend the use of N95s and other similar disposable respirators.

Due to increased supply of National Institute of Occupational Safety and Health-approved respirators, there is likely to be sufficient supply of respirators available domestically to allow organizations to transition away from decontamination or bioburden reduction and reuse of respirators intended as single use items, FDA notes.

Specifically, FDA recommends:

  • Only using decontaminated or bioburden-reduced respirators when there is an insufficient supply of facepiece filtering respirators (FFRs) or the organization is unable to obtain an adequate supply.
  • Hospitals and other organizations increase their inventory of available NIOSH-approved respirators, including N95s and other FFRs, elastomerics, and powered air-purifying respirators.

If you have questions, please contact AHA at 800-424-4301.

Related Resources

Action Alert
Please contact your representatives today and ask them to sign onto a House Dear Colleague letter to Department of Health and Human Services (HHS) Secretary…
Other Resources
AtlantiCare relies on efficient and effective collaboration and communication to vaccinate communities.
Other Resources
A team of doctors and scientists at UVA Health answers the public’s questions about deployment, efficacy and safety of all COVID-19 vaccines.
Other Resources
Armed with his guitar, a physician has been entertaining people getting their shots at the Mary Washington Healthcare COVID-19 vaccine clinic.
AHA urges the Department of Health and Human Services to extend the deadline for hospitals and other health care providers to use their COVID-19 Provider…
The American Hospital Association urged the Centers for Medicare…